Low-cap pot: Small cannabis companies
23 No. of Symbols
−0.080CAD
−14.52 MCAD
5.31 MCAD
147.03 M
About PHARMACIELO LTD
Sector
Industry
CEO
Marc Lustig
Website
Headquarters
Toronto
Founded
2014
ISIN
CA71716K1012
FIGI
BBG00J4XKS34
PharmaCielo Ltd. operates as a pharmaceutical company. It engages in the processing and supplying all natural, medicinal-grade cannabis oil extracts, and related products to large channel distributors. PharmaCielo's principal and wholly owned subsidiary is PharmaCielo Colombia Holdings S.A.S. The company was founded on July 14, 2014 and is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where PCLO is featured.
Frequently Asked Questions
The current price of PCLO is 0.180 CAD — it has increased by 2.86% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange PHARMACIELO LTD stocks are traded under the ticker PCLO.
PHARMACIELO LTD is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
PCLO stock is 8.82% volatile and has beta coefficient of 2.41. Check out the list of the most volatile stocks — is PHARMACIELO LTD there?
PCLO earnings for the last quarter are −0.02 CAD per share, whereas the estimation was −0.02 CAD resulting in a 0% surprise. The estimated earnings for the next quarter are −0.01 CAD per share. See more details about PHARMACIELO LTD earnings.
PHARMACIELO LTD revenue for the last quarter amounts to 2.12 M CAD despite the estimated figure of 4.92 M CAD. In the next quarter revenue is expected to reach 6.85 M CAD.
Yes, you can track PHARMACIELO LTD financials in yearly and quarterly reports right on TradingView.
PCLO stock has fallen by 32.08% compared to the previous week, the month change is a 28.57% rise, over the last year PHARMACIELO LTD has showed a 21.74% decrease.
PCLO net income for the last quarter is −2.76 M CAD, while the quarter before that showed −3.58 M CAD of net income which accounts for 22.99% change. Track more PHARMACIELO LTD financial stats to get the full picture.
Today PHARMACIELO LTD has the market capitalization of 27.91 M, it has increased by 21.74% over the last week.
No, PCLO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PCLO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMACIELO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMACIELO LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMACIELO LTD stock shows the sell signal. See more of PHARMACIELO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMACIELO LTD EBITDA is −8.21 M CAD, and current EBITDA margin is −161.84%. See more stats in PHARMACIELO LTD financial statements.